Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: Analysis of 310 pancreatic resection patients at multiple high-volume centers

Pancreas

Volumn 42, Issue 5, 2013, Pages 883-888

  Shimizu, Yasuhiro ^a   Yamaue, Hiroki ^b   Maguchi, Hiroyuki ^c   Yamao, Kenji ^a   Hirono, Seiko ^b   Osanai, Manabu ^c   Hijioka, Susumu ^a   Hosoda, Waki ^a   Nakamura, Yasushi ^b   Shinohara, Toshiya ^c   Yanagisawa, Akio ^d  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c TEINE KEIJINKAI HOSPITAL   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cyst size of BPD; Diameter of MPD; EUS; Multicenter analysis; Mural nodule; Predictor of malignant IPMN

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; PANCREAS DUCT; PANCREAS RESECTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84880055355     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31827a7b84     Document Type: Article

References (33)

1. Ohashi K, Murakami Y, Maruyama M., et al Four cases of mucous secreting pancreatic cancer. Prog Diagn Endosc. 1982;20:348-351.
2. Kloppel G, Solcia E, Longnecker D.S., et al World Health Organization International Histological Typing of Tumors of the Exocrine Pancreas. Berlin, Germany: Springer; 1996:1-61.
3. Longnecker DS, Adler G, Hruban R.H., et al Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC Press; 2000:237-241.
4. Tanaka M, Chari S, Adsay V., et al International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
5. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678-685.
6. Terris B, Ponsot P, Paye F., et al Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372-1377.
7. Sugiyama M, Izumisato Y, Abe N., et al Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003;90:1244-1249.
8. Sohn TA, Yeo CJ, Cameron J.L., et al Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788-797.
9. Schmidt CM, White PB, Waters J.A., et al Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-651.
10. Tanaka M, Castillo CF, Adsay V, et al International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183-197.
11. Yamaguchi K, Kanemitsu S, Hatori T., et al Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571-580.
12. Hanley JA, McNeil BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
13. Harrell FE J.r., Califf RM, Pryor D.B., et al Evaluating the yield of medical tests. JAMA. 1982;247:2543-2546.
14. Jang JY, Kim SW, Ahn Y.J., et al Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124-132.
15. Nagai K, Doi R, Kida A., et al Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg. 2008;32:271-278.
16. Yang AD, Melstrom LG, Bentrem D.J., et al Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007;142:529-534.
17. Kawamoto S, Lawler LP, Horton K.M., et al MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma. AJR Am J Roentgenol. 2006;186:687-695.
18. Albert J, Schilling D, Breer H., et al Mucinous cystadenomas and intraductal papillary mucinous tumors of the pancreas in magnetic resonance cholangiopancreatography. Endoscopy. 2000;32:472-476.
19. Kobayashi G, Fujita N, Noda Y., et al Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS. J Gastroenterol. 2005;40:744-751.
20. Yamao K, Nakamura T, Suzuki T., et al Endoscopic diagnosis and staging of mucinous cystic neoplasms and intraductal papillary-mucinous tumors. J Hepatobiliary Pancreat Surg. 2003;10:142-146.
21. Furukawa T, Oohashi K, Yamao K., et al Intraductal ultrasonography of the pancreas: development and clinical potential. Endoscopy. 1997;29:561-569.
22. Yamao K, Ohashi K, Nakamura T., et al Efficacy of peroral pancreatoscopy in the diagnosis of pancreatic diseases. Gastrointest Endosc. 2003;57:205-209.
23. Hirono S, Tani M, Kawai M., et al The carcinoembryonic antigen level in the pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255:517-522.
24. Adsay NV, Fukushima N, Furukawa T., et al Intraductal neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumors of Digestive System. Lyon, France: WHO Press; 2010:304-313.
25. Japan Pancreatic Society. Classification of Pancreatic Carcinoma. 2nd ed. Tokyo, Japan: Kanehara & Co Ltd; 2003.
26. Japan Pancreatic Society. Classification of Pancreatic Carcinoma. 3rd ed. Tokyo, Japan: Kanehara & Co Ltd; 2011.
27. Nagai K, Doi R, Ito T., et al Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg. 2009;16:353-358.
28. Pelaez-Luna M., Chari ST, Smyrk T.C., et al Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759-1764.
29. Sadakari Y, Ienaga J, Kobayashi K., et al Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas. 2010;39:232-236.
30. Shimizu Y, Kanemitsu Y, Sano T., et al A nomogram for predicting the probability of carcinoma in patients with intraductal papillary-mucinous neoplasm. World J Surg. 2010;34:2932-2938.
31. Del Favero G., Fabris C, Angonese C., et al Cytology in the diagnosis of pancreatic cancer. Int J Pancreatol. 1988;3(SUPPL. 1):S137-S141.
32. Nakaizumi A, Tatsuta M, Uehara H., et al Usefulness of simple endoscopic aspiration cytology of pancreatic juice for diagnosis of early pancreatic neoplasm. A prospective study. Dig Dis Sci. 1997;42:1796-1803.
33. Yamaguchi K, Nakamura M, Shirahane K., et al Pancreatic juice cytology in IPMN of the pancreas. Pancreatology. 2005;5:416-421.